• American Heart Association Postdoctoral Fellowship Awards

    December 03, 2018

    Congratulations to three HeRO 2019 American Heart Association Postdoctoral Fellowship Awardees: Dr. Paul Lee, Dr. Jinqi Fan, and Dr. Nam Kyun Kim!

  • Dr. Serpooshan Chosen for Teaching Fellowship

    November 21, 2018

    Dr. Vahid Serpooshan has been selected for the Woodruff Health Educators Academy’s (WHEA) Teaching Fellowship inaugural cohort!

  • For the Kids Raises $46,760 for Sibley Heart Center & HeRO

    November 16, 2018

    Thank you For The Kids @ Georgia Tech for raising $46,760 in only 24 hours!  Funds will support research and patient support for Sibley Heart Center Cardiology and HeRO! 

  • Newsletter: Summer 2018

    August 18, 2018

  • Dr. Xu’s Publication in ACS Chemical Biology

    July 18, 2018

    The term “stem cell” is increasingly stretchy. Orthopedic specialists have been using it when referring to bone marrow concentrate or platelet rich plasma, which are marketed as treatments for joint pain. At Lab Land, we have an interest in pluripotent stem cells, which can differentiate into many types of tissues

  • Dr. Buckley Awarded R21

    June 29, 2018

    Sickle cell disease (SCD) in children is associated with a 250x greater risk of stroke than the general population. Moreover, children with SCD have significantly diminished IQ's, attention deficits, and impaired executive skills and visuo-spatial memory compared with age-matched…

  • Dr. Maxwell Awarded JFF Pilot Grant

    June 29, 2018

    "The Role of Paracrine Factors in Cardiac Progenitor Cell-mediated Cardiac Regeneration" Josh Maxwell, PhD (Emory University) Stem cells such as cardiac progenitor cells (CPCs) have shown promise in restoring cardiac function in pediatric population for various cardiac pathologies including heart…

  • Dr. Xu Awarded RO1

    May 15, 2018

    The Dr. Chunhui Xu's RO1 award aims to examine stem cell-derived cardiomyocytes in response to a multipronged approach for promotion of cardiomyocyte maturation. Findings from this study will help to address key issues facing applications of cardiomyocytes derived from human pluripotent stem cells in cardiotoxicity testing, disease modeling, developmental biology and regenerative medicine.